{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:00Z","timestamp":1761182940871,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jiac.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T02:55:36Z","timestamp":1541213736000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An \u03b1-Lipoic acid derivative, and anti-ROS agent, prevents the acquisition of multi-drug resistance in clinical isolates of Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"25","author":[{"given":"Sachiko","family":"Hayakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizou","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-1245","authenticated-orcid":false,"given":"Toshiaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7419-3293","authenticated-orcid":false,"given":"Shigeru","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.10.003_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2015.06.024","article-title":"Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes","volume":"37","author":"Sligl","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.003_bib2","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AMR surveillance-Europe-2016.pdf [Accessed 4 July 2018]."},{"key":"10.1016\/j.jiac.2018.10.003_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2010.01.003","article-title":"Sub-lethal antibiotic treatment leads to multi-drug resistance via radical-induced mutagenesis","volume":"37","author":"Kohanski","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.jiac.2018.10.003_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1099\/mic.0.081166-0","article-title":"The lack of OmpF, but not OmpC, contributes to increased antibiotic resistance in Serratia marcescens","volume":"160","author":"Moya-Torres","year":"2014","journal-title":"Microbiology"},{"key":"10.1016\/j.jiac.2018.10.003_bib5","doi-asserted-by":"crossref","first-page":"13586","DOI":"10.1073\/pnas.0803391105","article-title":"The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jiac.2018.10.003_bib6","article-title":"Premature termination of MexR leads to overexpression of MexAB-OprM efflux pump in Pseudomonas aeruginosa in a tertiary referral hospital in India","volume":"11","author":"Choudhury","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2018.10.003_bib7","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1128\/AAC.49.6.2276-2282.2005","article-title":"Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation","volume":"49","author":"Ciofu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib8","doi-asserted-by":"crossref","first-page":"1000264","DOI":"10.4172\/2327-5073.1000264","article-title":"Exposure to reactive oxygen species and piperacillin leads to multidrug resistance in Pseudomonas aeruginosa PAO1","volume":"5","author":"Hayakawa","year":"2016","journal-title":"Clin Microbiol"},{"key":"10.1016\/j.jiac.2018.10.003_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CCM.0b013e318206b7e7","article-title":"New lipoic acid derivative drug sodium zinc dihydrolipoylhistidinate prevents cardiac dysfunction in an isolated perfused rat heart model","volume":"39","author":"Hagiwara","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2018.10.003_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00595-010-4481-z","article-title":"The \u03b1-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy- induced alopecia in a rat model: a pilot study","volume":"41","author":"Hagiwara","year":"2011","journal-title":"Surg Today"},{"key":"10.1016\/j.jiac.2018.10.003_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jss.2011.01.011","article-title":"New \u03b1- lipoic acid derivative, DHL-HisZn, ameliorates renal ischemia-reperfusion injury in rats","volume":"174","author":"Koga","year":"2012","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jiac.2018.10.003_bib12","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1517\/14728222.2011.640320","article-title":"Antiproliferative effects of a new \u03b1-lipoic acid derivative, DHL-HisZnNa, in HT29 human colon cancer cells in\u00a0vitro","volume":"16","author":"Kono","year":"2012","journal-title":"Expert Opin Ther Targets"},{"year":"2017","series-title":"European committee on antimicrobial susceptibility testing, Breakpoint tables for interpretation of MICs and zone diameters, version 7.1","key":"10.1016\/j.jiac.2018.10.003_bib13"},{"key":"10.1016\/j.jiac.2018.10.003_bib14","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1128\/JCM.42.12.5644-5649.2004","article-title":"Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa","volume":"42","author":"Curran","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2018.10.003_bib15","article-title":"Population structure of Pseudomonas aeruginosa from five mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235","volume":"10","author":"Maatallah","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2018.10.003_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jam.13016","article-title":"Applying a PCR-based open-reading frame typing method for easy genotyping and molecular epidemiological analysis of Pseudomonas aeruginosa","volume":"120","author":"Suzuki","year":"2015","journal-title":"J\u00a0Appl Microbiol"},{"key":"10.1016\/j.jiac.2018.10.003_bib17","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1128\/AAC.00816-09","article-title":"Efflux pumps, OprD porin, AmpC \u03b2-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"54","author":"Tom\u00e1s","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2180-10-217","article-title":"Efflux pumps expression and its association with porin down-regulation and \u03b2-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil","volume":"10","author":"Xavier","year":"2010","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jiac.2018.10.003_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jac\/dkg173","article-title":"Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1","volume":"51","author":"Morita","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/AAC.01581-12","article-title":"Quantitative contributions of target\u00a0alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance","volume":"57","author":"Bruchmann","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib21","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/AAC.00680-12","article-title":"Pan-\u03b2-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities","volume":"56","author":"Moya","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib22","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1021\/bi100268k","article-title":"Study of multidrug membrane transporter of single living Pseudomonas aeruginosa cells using size-dependent plasmonic nanoparticle optical probes","volume":"49","author":"Nallathamby","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jiac.2018.10.003_bib23","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/AAC.00148-07","article-title":"Resistance mechanisms of multi-resistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation","volume":"51","author":"Henrichfreise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.mib.2009.06.018","article-title":"Role of reactive oxygen species in antibiotic action and resistance","volume":"12","author":"Dwyer","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jiac.2018.10.003_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/ars.2012.4827","article-title":"Redox reactions and microbial killing in the neutrophil phagosome","volume":"18","author":"Winterbourn","year":"2013","journal-title":"Antioxd Redox Signal"},{"key":"10.1016\/j.jiac.2018.10.003_bib26","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1128\/jb.169.7.2967-2976.1987","article-title":"Mutagenesis and stress responses induced in Escherichia coli by hydrogen peroxide","volume":"169","author":"James","year":"1987","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jiac.2018.10.003_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2018.10.003_bib28","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/mr.60.4.575-608.1996","article-title":"Proton-dependent multidrug efflux systems","volume":"60","author":"Paulsen","year":"1996","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.jiac.2018.10.003_bib30","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.3402\/ljm.v6i0.5870","article-title":"Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa","volume":"6","author":"Askoura","year":"2011","journal-title":"Libyan J Med"},{"key":"10.1016\/j.jiac.2018.10.003_bib31","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/jac\/dkv111","article-title":"Enhanced efficacy of putative efflux pump inhibitor\/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in\u00a0vivo infection model","volume":"70","author":"Adamson","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3947\/ic.2015.47.2.98","article-title":"Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitor","volume":"47","author":"Adabi","year":"2015","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jiac.2017.08.009","article-title":"Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis","volume":"24","author":"Nakai","year":"2018","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.10.003_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","article-title":"Neuroprotection by the metabolic antioxidant alpha-lipoic acid","volume":"22","author":"Packer","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jiac.2018.10.003_bib36","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.bmc.2006.12.042","article-title":"Modulating effects of a novel skin- lightening agent, \u03b1-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products","volume":"15","author":"Tsuji-Naito","year":"2007","journal-title":"Bioorg Med Chem"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:45Z","timestamp":1761159465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1341321X18303921"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An \u03b1-Lipoic acid derivative, and anti-ROS agent, prevents the acquisition of multi-drug resistance in clinical isolates of Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}